Blog
How Companies Can End a Culture of Overwork | Harvard Business Review
While there are often personal reasons people become workaholics, the environments they’re in can exacerbate their...
When Asking Too Many Questions Undermines Your Leadership | Harvard Business Review
Although it’s widely accepted that good leaders are good learners, a learning mentality can also have a darker side....
Using Persuasion to Spur Lasting Organizational Change | Harvard Business Review
There are well-known tactics for persuading others, coauthor Robert Cialdini’s prominent among them. But when leaders...
Inside the First Year as a CEO | Harvard Business Review
CEO performance reverberates well beyond the corner office, affecting everyone from employees to shareholders,...
What High Achievers Need from Their Mentors | Harvard Business Review
Even the best-performing individuals need guidance to avoid complacency, continue growing, and reach new heights. High...
Teamwork at the Top | Harvard Business Review
Teamwork is difficult at any level, but for top teams, the challenges expand exponentially. They are responsible for...
Cytiva report recommends strategy for achieving sustainability | Fierce Pharma
In a sustainability survey of biopharma execs conducted by Cytiva and FT Longitude, 63% see sustainability as...
New Rules for Teamwork | Harvard Business Review
Not that long ago, teams were typically composed of people with similar skills working in the same place. Their...
Why Cynics Are Less Likely to Succeed | Harvard Business Review
New research in behavioral science has revealed that cynical thinking stands in the way of success in the workplace....
Why Leadership Teams Fail | Harvard Business Review
In pursuit of strong performance, CEOs often overlook a critical factor in organizational success: the health of their...
Where Data-Driven Decision-Making Can Go Wrong | Harvard Business Review
When considering internal data or the results of a study, often business leaders either take the evidence presented as...
How GLP-1s tanked and reshaped the medtech stock market | Mass Device
Promising clinical trial results on glucagon-like peptide 1 agonists (GLP-1s) created a seismic shift in the medtech...
Hire with SEC
Schedule a free consultation today to experience our innovative, industry-leading executive search and engineer recruiting hiring process firsthand.
"*" indicates required fields










